CPR Therapeutics

We are happy to announce that we have taken a big step forward toward achieving our milestones! CPR Therapeutics was selected as one of the four companies for a three-month, in-person program for early-stage life sciences and healthcare companies, operated jointly by Auxilium, a Worcester-based accelerator and innovation studio, and Massachusetts Biomedical Initiatives (MBI), the Commonwealth's longest-running nonprofit life sciences incubator. The accelerator is extremely competitive because selected companies receive a significant investment of $250K along with mentorship, fundraising support, and access to both organizations' investor and industry networks. https://lnkd.in/gBvxhPcV

We are thrilled to announce that Dr. Scott Youngquist has joined our Board of Science Advisors. He has spent his career on the front lines of cardiac arrest research and prehospital care, and he understands better than almost anyone the gap between where resuscitation medicine stands today and where it needs to go. https://lnkd.in/dum6iu7p

Why do ER doctors need to be MacGyvers of medicine? Why emergency equipment has had less innovation, and why CPR Therapeutics’s research matters more than ever? Our founder, Dr. Norman Paradis reviews the founding of the company and the uncommon situation CPR-T finds itself in - working largely on its own to innovate cardiopulmonary resuscitation. Podcast link: https://lnkd.in/eyuYTirz

We are pleased to announce another allowance from USPTO: US Patent for Advances in Cardioversion and Pacing  These inventions look particularly effective in the treatment of atrial fibrillation, the most common disturbance of rhythm. This patent will allow us to help an even wider spectrum of patients. https://lnkd.in/eXXtrFhE

We are pleased for every confirmation that the time for the circumferential CPR we’re developing has come! Thank you for this important reminder @Yoshihisa Matsushima,Tatsuhiro Shibata, @Kodai Shibao, @Rei Yamakawa, Miyu Hayashida, @Toshiyuki Yanai, @Takashi Ishimatsu, Takahiro Homma, @Shoichiro Nohara, @Maki Otsuka, @Yoshihiro Fukumoto. Read what our founder Norman Paradis said about it: https://lnkd.in/erk-9wpE

There’s no better way to start the day than by reviewing the data that sets our device apart from others on the market. Pleased to share that Brattleboro Reformer has featured article about our advanced automated CPR system. "Our device, because it wraps all the way around, can do 700 to 800 with no fractures," said Paradis, who said the first device will be out in about two years, a specialized device for use in a hospital. " Full article: https://lnkd.in/eM26pr7V